title: Immunoreactivity for cyclin D1 is a reliable marker of gene aberration in plasma cell myeloma but does not specify patients prognosis.
authors: Giancarlo
authors: G
authors: Pruneri
authors: Alessandra
authors: A
authors: Alietti
authors: Luca
authors: L
authors: Agnelli
authors: Fortunato
authors: F
authors: Morabito
authors: Daniele
authors: D
authors: Laszlo
authors: Liliana
authors: L
authors: Calabrese
authors: Sonia
authors: S
authors: Fabris
authors: Francesco
authors: F
authors: Bertolini
authors: Alberto
authors: A
authors: Agazzi
authors: Luca
authors: L
authors: Bottiglieri
authors: Paola Rafaniello
authors: PR
authors: Raviele
authors: Luca
authors: L
authors: Baldini
authors: Stefano
authors: S
authors: Pileri
authors: Elena
authors: E
authors: Sabattini
authors: Silvano
authors: S
authors: Bosari
authors: Patrick
authors: P
authors: Maisonneuve
authors: Giorgio
authors: G
authors: Lambertenghi-Deliliers
authors: Francesco
authors: F
authors: Bertoni
authors: Giovanni
authors: G
authors: Martinelli
authors: Giuseppe
authors: G
authors: Viale
authors: Antonino
authors: A
authors: Neri
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000235:genetics / Q000276:immunology; D056741:Cyclin D; D016213:Cyclins / Q000032:analysis* / Q000235:genetics / Q000276:immunology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000235:genetics* / Q000401:mortality; D011379:Prognosis; D016019:Survival Analysis; D014178:Translocation, Genetic
chemical_list: D014408:Biomarkers, Tumor; D056741:Cyclin D; D016213:Cyclins